Autres langues Dicot AB

Actions

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 00:00:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,268 ^SEK	+0,56 %		+8,06 %	-15,72 %

23/04	Dicot AB (publ) annonce des résultats positifs en matière d'innocuité et d'amélioration de l'efficacité dans le cadre d'une étude de phase 1	CI
11/03	Dicot AB (publ) annonce la fin du recrutement pour l'étude de phase 1 de Dicot	CI

Good safety and improved erectile function reported from Dicot's phase 1 study	23/04
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	23/04
Dicot in preparation for clinical phase 2a trial	12/04
Reporting from Dicot's phase 1 study end of April	05/04
BioStock: Dicot's phase I study fully recruited	14/03
Recruitment completed in Dicot's phase 1 trial	11/03
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	11/03
Dicot's CEO tells BioStock: "Several prominent people want to be part of the journey"	29/02
Dicot AB Year-End Report 2023	26/02
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26/02
BioStock: Good safety profile for Dicot's LIB-01	26/01
Positive results from the first part of Dicot's phase 1 study	23/01
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	23/01
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	11/01
Dicot applies for patent covering new manufacturing technology	11/01
Dicot Applies for Patent Covering New Manufacturing Technology	11/01
Dicot invited to present at ESSM for the third time	05/01
BioStock: Interim results from Dicot's phase I study to be released earlier than expected	20/12
Partial results from Dicot's phase 1 trial to be presented early next year	15/12
Dicot AB Announces Partial Results from Phase 1 Trial to Be Presented Early Next Year	15/12

Aucun résultat pour cette recherche